38Ä¿¹Â´ÏÄÉÀÌ¼Ç ·Î°í
½Ç½Ã°£ ÀαâÁÖµ¿
ºñ»óÀå.
K-OTC.
Äڳؽº.
Àå¿Ü½ÃÀå NO.1 µ¶Á¡Àû Á¡À¯À² ±â·Ï
»¡°£»ö¸Å¸Å ¸Åµµ¸Å¼ö ÆË´Ï´Ù Àå¿Ü½Ã¼¼
ºñ»óÀå¸Å¸Å ½Ã¼¼Á¤º¸ ºñ»óÀå(Àå¿Ü) IPO°ø¸ð IPO¿¹Á¤ºÐ¼® ±â¾÷Á¤º¸ ÁÖÁÖµ¿È£È¸ K-OTC Äڳؽº ÄÚ½º´Ú/°Å·¡¼Ò Àüü ¸Þ´ºº¸±â 38¸Ó´ÏÃæÀü
±â¾÷°³¿ä
Á¾¸ñ¸í   ¾ÆÀ̺öÅ×Å©³î·ÎÁö ÁøÇà»óȲ   ½Å±Ô»óÀå
½ÃÀ屸ºÐ   ÄÚ½º´Ú Á¾¸ñÄÚµå   460470
¾÷Á¾   ±× ¿Ü ±âŸ ÀüÀÚºÎÇ° Á¦Á¶¾÷
´ëÇ¥ÀÚ   ±èÇÊÇÑ ±â¾÷±¸ºÐ   Áß¼ÒÀϹÝ
º»Á¡¼ÒÀçÁö   ´ëÀü±¤¿ª½Ã À¯¼º±¸ Å×Å©³ë4·Î 17 ºñµ¿ 415È£(°üÆòµ¿, ºñÁî¼¾ÅÍ)
ȨÆäÀÌÁö   www.ivimtech.com ´ëÇ¥ÀüÈ­   042-825-7450
ÃÖ´ëÁÖÁÖ   -
¸ÅÃâ¾×   1,338 (¹é¸¸¿ø) ¹ýÀμ¼ºñ¿ëÂ÷°¨Àü
°è¼Ó»ç¾÷ÀÌÀÍ
  -9,735 (¹é¸¸¿ø)
¼øÀÌÀÍ   -9,735 (¹é¸¸¿ø) ÀÚº»±Ý   7,482 (¹é¸¸¿ø)

°ø¸ðÁ¤º¸
ÃÑ°ø¸ðÁֽļö   2,234,000 ÁÖ ¾×¸é°¡   500 ¿ø
»óÀå°ø¸ð   ½ÅÁÖ¸ðÁý : 2,234,000 ÁÖ (100%) 
Èñ¸Á°ø¸ð°¡¾×   7,300 ~ 8,500 ¿ø û¾à°æÀï·ü   1094.66:1 (ºñ·Ê 2189:1)
È®Á¤°ø¸ð°¡   10,000 ¿ø °ø¸ð±Ý¾×   22,340 (¹é¸¸¿ø)
ÁÖ°£»ç   »ï¼ºÁõ±Ç Áֽļö: 558,500 ÁÖ   /   û¾àÇѵµ: 27,000~33,000 ÁÖ

°ø¸ðû¾àÀÏÁ¤
ÁÖ¿äÀÏÁ¤ ¼ö¿ä¿¹ÃøÀÏ   2024.07.15  ~   2024.07.19
°ø¸ðû¾àÀÏ   2024.07.25  ~   2024.07.26
¹èÁ¤°ø°íÀÏ(½Å¹®)   2024.07.30 (ÁÖ°£»ç ȨÆäÀÌÁö ÂüÁ¶)
³³ÀÔÀÏ   2024.07.30
ȯºÒÀÏ   2024.07.30
»óÀåÀÏ   2024.08.06
°ø¸ð»çÇ×
È®Á¤°ø¸ð°¡   10,000 ¿ø
   ÁÖ´ç¾×¸é°¡ :  500 ¿ø
   Èñ¸Á°ø¸ð°¡¾× :  7,300 ~ 8,500 ¿ø
ÃÑ°ø¸ðÁֽļö   2,234,000 ÁÖ
   °ø¸ð±Ý¾× : 22,340 (¹é¸¸¿ø)
±×
·ì
º°
¹è
Á¤
¿ì¸®»çÁÖÁ¶ÇÕ   ÁÖ      Ã»¾àÁõ°Å±ÝÀ² : 100%
±â°üÅõÀÚÀÚµî   1,675,500 ÁÖ  (75.0%)    ÃÖ°íÇѵµ :  - ÁÖ
ÀϹÝû¾àÀÚ   558,500 ÁÖ  (25.0%)    Ã»¾àÁõ°Å±ÝÀ² : 50%
 Ã»¾à ÃÖ°íÇѵµ :  27,000~33,000 ÁÖ  ÃÖÀú :  - ÁÖ
IRÀÏÁ¤
IRÀÏÀÚ  2024.07.12 IRÀå¼Ò/½Ã°£    ±â°ü :
  ÀÏ¹Ý : Çѱ¹IRÇùÀÇȸ-¿Â¶óÀÎ PM 03:10
¼ö¿ä¿¹Ãø°á°ú
±â°ü°æÀï·ü  1011.50:1 Àǹ«º¸À¯È®¾à  0.49%
½Å±Ô»óÀå
½Å±Ô»óÀåÀÏ  2024.08.06 ÇöÀç°¡  6,150 ¿ø (2.16%)

Àǹ«º¸À¯ È®¾àºñÀ²
±¸ºÐ ½Åû¼ö·®(´ÜÀ§:ÁÖ)
6°³¿ù È®¾à 5,673,000
3°³¿ù È®¾à 1,163,000
1°³¿ù È®¾à 1,084,000
15ÀÏ È®¾à 405,000
ÇÕ°è8,325,000
ÃÑ ¼ö·® ´ëºñ ºñÀ²(%)0.49%

¼ö¿ä¿¹Ãø Âü¿©³»¿ª
Âü¿©°Ç¼ö (´ÜÀ§:°Ç) ½ÅûÁֽļö (´ÜÀ§:ÁÖ) ´Ü¼ø°æÀï
2,110 1,694,775,907 1011.50:1

¼ö¿ä¿¹Ãø ½Åû°¡°ÝºÐÆ÷
±¸ºÐ Âü¿©°Ç¼ö (´ÜÀ§:°Ç) ½ÅûÁֽļö (´ÜÀ§: ÁÖ) ºñÀ²(%)
°¡°Ý ¹ÌÁ¦½Ã 1516,709,0001.0%
10,000¿ø ÃÊ°ú 15721,232,427,52872.7%
10,000¿ø468390,050,12923.0%
8,500¿ø ÃÊ°ú ~ 10,000¿ø ¹Ì¸¸ 21,511,0000.1%
8,500¿ø 5050,394,2503.0%
7,300¿ø ÃÊ°ú ~ 8,500¿ø ¹Ì¸¸ 22,472,0000.1%
7,300¿ø 11,212,0000.1%
7,300¿ø ¹Ì¸¸ ---
ÇÕ°è 2,110°Ç 1,694,775,907ÁÖ 100%

º»Áú°¡Ä¡ºÐ¼®

 ¾ÆÀ̺öÅ×Å©³î·ÎÁö Àç ¹« ºñ À²  
±¸ºÐ 2023.12.312022.12.312021.12.31
¾ÈÁ¤¼º ºÎäºñÀ² 28.97 %  0.00 %  0.00 %  
À¯µ¿ºñÀ² 822.30 %  37.53 %  13.32 %  
¼öÀͼº ÀÚ±âÀÚº»¼öÀÍ·ü -39.35 %  48.64 %  25.15 %  
¿µ¾÷ÀÌÀÍ·ü -64.63 %  -249.07 %  -508.94 %  
¼ºÀ强 ¸ÅÃâ¾×Áõ°¡À² 236.20 %  154.18 %  0.00 %  
¿µ¾÷ÀÌÀÍÁõ°¡À² -12.76 %  24.39 %  0.00 %  


 ¾ÆÀ̺öÅ×Å©³î·ÎÁö ÁÖ °¡ Áö Ç¥
±¸ ºÐ 2023.12.312022.12.312021.12.31
  EPS (ÁÖ´ç¼øÀÌÀÍ) -9,955 ¿ø  -19,217 ¿ø  -5,172 ¿ø  
  PER (ÁÖ°¡¼öÀͺñÀ²)
  °ø¸ð°¡ ´ëºñ
-0.85  -0.44  -1.64  
  BPS (ÁÖ´ç¼øÀڻ갡ġ) 25,301 ¿ø  -39,510 ¿ø  -20,561 ¿ø  
  PBR (ÁÖ°¡¼øÀÚ»êºñÀ²) 0.34  -0.22  -0.41  
  SPS (ÁÖ´ç¸ÅÃâ¾×) 8,873 ¿ø  2,639 ¿ø  1,038 ¿ø  
  PSR (ÁÖ°¡¸ÅÃâ¾×ºñÀ²) 0.96  3.22  8.19  

°ø¸ðºÐ¼®

1.»ç¾÷ÇöȲ

-¾ÆÀ̺öÅ×Å©³î·ÎÁö (IVIM Technology, Inc)´Â Çѱ¹°úÇбâ¼ú¿ø(KAIST)ÀÌ °³¹ßÇÑ Çõ½ÅÀûÀÎ »ýüÇö¹Ì°æ (IntraVital Microscopy: IVM) ¿øõ±â¼úÀ» Åä´ë·Î 2017³â 6¿ù¿¡ ¼³¸³µÇ¾ú½À´Ï´Ù. ¼¼°è ÃÖÃÊ·Î ¿ÃÀοø (All-in-One) ÀÏüÇü »ýüÇö¹Ì°æ ÀåºñÀÇ »ó¿ëÈ­¿¡ ¼º°øÇÏ¿© »ì¾ÆÀÖ´Â »ýü ³»ºÎÀÇ ´Ù¾çÇÑ Á¶Á÷°ú Àå±â¸¦ ±¸¼ºÇÏ´Â ¼¼Æ÷µé°ú ¹ÙÀÌ¿À ¾à¹°À» µ¿½Ã¿¡ À̹Ì¡Çϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ßÀ» Àü¹®À¸·Î ÇÏ´Â »ý¸í °øÇРȸ»çÀÔ´Ï´Ù.

¾ÆÀ̺öÅ×Å©³î·ÎÁöÀÇ »ç¾÷ ¿µ¿ªÀº Àåºñ ÆǸÅ, CRO ¼­ºñ½º, AI ±â¹Ý ÀÇ·á±â±â °³¹ß µîÅ©°Ô 3°¡Áö·Î ºÐ·ùÇÒ ¼ö ÀÖÀ¸¸ç, »ç¾÷ ¿µ¿ªÀº »ýü ³» °íÇØ»óµµ ¿µ»óÀ» À§ÇÑ Çõ½ÅÀûÀÎ ±â¼ú°ú °íÇ°Áú ¼­ºñ½º¸¦ ÅëÇØ Ã·´Ü ÀÇ·á ¹× »ý¸í°úÇÐ ºÐ¾ß¸¦ ¹ßÀü½ÃÅ°°Ú´Ù´Â ÀÇÁö¸¦ ¹Ý¿µÇÏ°í ÀÖ½À´Ï´Ù. ´ç»çÀÇ »ýüÇö¹Ì°æ Àåºñ´Â »ì¾ÆÀÖ´Â »ýü ³» ´ÜÀÏ ¼¼Æ÷ ¹× ´ÙÁ¾ ¼¼Æ÷ °£ »óÈ£ÀÛ¿ë°ú ´Ü¹éÁú, ¾à¹° ºÐÀÚ±îÁö 3Â÷¿ø ½Ç½Ã°£ ¿µ»óÈ­°¡ °¡´ÉÇÏ¿© ´Ù¾çÇÑ Áúº´ÀÇ »ýü ³» ¹ß»ý °úÁ¤ÀÇ ºÐ¼®Àº ¹°·Ð ½Å¾àÈĺ¸¹°ÁúµéÀÇ »ýü ³» Àü´Þ°ú È¿´ÉÀÇ ºÐ¼®±îÁö ¼öÇàÇÏ´Â °ÍÀÌ °¡´ÉÇÑ Ã·´Ü ¿µ»ó ÀåºñÀÔ´Ï´Ù. »ýü ³» ¼¼Æ÷ ¿µ»ó (In vivo3D/4D cell imaging, tracking & monitoring), »ýü ³» ¾à¹° È¿´É ¿µ»ó (In vivo imaging of drug efficacy), »ýü ³» ¾à¹° Àü´Þ ¿µ»ó (In vivo imaging of drug delivery)À» Æó, ½ÉÀå, ³ú, ¼ÒÀå, ´ëÀå µîÀÇ ¸ðµç »ýü Á¶Á÷¿¡¼­ ÃÔ¿µÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Å¾à°³¹ß °úÁ¤¿¡¼­ ÀúºÐÀÚÈ­ÇÕ¹°µµ Æ÷ÇÔÇÏ¿© Ç×üÀǾàÇ°, »ý¹°ÇÐÀû Á¦Á¦, ¼¼Æ÷Ä¡·áÁ¦, À¯ÀüÀÚÄ¡·áÁ¦ µîÀÌ Æ÷ÇÔµÈ ¹ÙÀÌ¿ÀÀǾàÇ° ºÐ¾ßÀÇ »õ·Î¿î Ä¡·á¾à¹°ÀÇ »ýü ³» Ç¥ÀûÀ¸·ÎÀÇ Àü´Þ ¹× È¿°ú¸¦ »ýü ³»¿¡¼­ Á÷Á¢ÀûÀ¸·Î ºÐ¼®(In vivo drug testing)ÀÌ °¡´ÉÇÏ¿© ±Û·Î¹ú ¹ÙÀÌ¿ÀÇコ ½ÃÀå¿¡¼­ ³ôÀº ±â¼úÀû È®À强°ú ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÇöÀç ±¹³» ½ÃÀåÀ» ¼±Á¡ÇÏ°í ÀÖ´Â Çö¹Ì°æ Àåºñ ¹× ±â¼ú·ÂÀ» ´ç»ç¸¦ ÅëÇر¹»êÈ­·Î Å» ¹Ù²ÞÇÏ¿© ±Û·Î¹ú ½ÃÀåÀ» ÁÖµµÇÒ ¼ö ÀÖ´Â ±âƲÀ» ¸¶·ÃÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëÇÕ´Ï´Ù.

2.¸ÅÃâÇöȲ

(´ÜÀ§ : õ¿ø)
±¸ºÐ 2024³â 1ºÐ±â 2023³â 2022³â 2021³â
(Á¦8±â 1ºÐ±â) (Á¦7±â) (Á¦6±â) (Á¦5±â)
¸ÅÃâ¾× ºñÀ² ¸ÅÃâ¾× ºñÀ² ¸ÅÃâ¾× ºñÀ² ¸ÅÃâ¾× ºñÀ²
»ýüÇö¹Ì°æ ³»¼ö 0.00% 1,160,091 25.80% 404,948 30.30% 300,273 57.00%
¼öÃâ 0.00% 2,586,668 57.50% 671,605 50.20% 0.00%
ÇÕ°è 0.00% 3,746,759 83.40% 1,076,553 80.50% 300,273 57.00%
À̹Ì¡ ³»¼ö 0.00% 0.00% 0.00% 0.00%
¿¢¼¼¼­¸® ¼öÃâ 28,298 28.50% 10,256 0.20% 0.00% 0.00%
¡¡ ÇÕ°è 28,298 28.50% 10,256 0.20% 0.00% 0.00%
CRO¼­ºñ½º ³»¼ö 41,600 41.90% 234,586 5.20% 170,262 12.70% 196,196 37.20%
¼öÃâ 0.00% 45,944 1.00% 6,630 0.50% 7,006 1.30%
ÇÕ°è 41,600 41.90% 280,530 6.20% 176,892 13.20% 203,202 38.60%
±âŸ ³»¼ö 19,158 19.30% 169,914 3.80% 83,104 6.20% 6,438 1.20%
¼öÃâ 10,342 10.40% 287,630 6.40% 1,346 0.10% 17,063 3.20%
ÇÕ°è 29,500 29.70% 457,544 10.20% 84,450 6.30% 23,501 4.50%
ÃÑÇÕ°è 99,398 100.00% 4,495,089 100.00% 1,337,895 100.00% 526,976 100.00%


3.À繫ÇöȲ

(1) À繫Àû ¼ºÀ强
(´ÜÀ§: õ¿ø)
±¸ºÐ 2021³âµµ 2022³âµµ 2023³âµµ 2023³â 1ºÐ±â 2024³â 1ºÐ±â
(Á¦5±â) (6±â) (Á¦7±â) (Á¦7±â 1ºÐ±â) (Á¦8±â 1ºÐ±â)
¸ÅÃâ¾× 526,975 1,337,894 4,495,089 555,343 99,398
(Áõ°¨·ü %) -56.21% 153.88% 235.98% N.A. -82.10%
¸ÅÃâÃÑÀÌÀÍ(¼Õ½Ç) -122,943 159,574 1,425,045 199,346 -91,878
(Áõ°¨·ü %) ÀûÀÚÀüȯ ÈæÀÚÀüȯ 793.03% N.A. ÀûÀÚÀüȯ
(¸ÅÃâÃÑÀÌÀÍ·ü %) -23.33% 11.93% 31.70% 35.90% -92.43%
¿µ¾÷ÀÌÀÍ(¼Õ½Ç) -2,677,552 -3,330,679 -2,905,070 -899,646 -1,314,068
(Áõ°¨·ü %) ÀûÀÚÁö¼Ó ÀûÀÚÁö¼Ó ÀûÀÚÁö¼Ó N.A. ÀûÀÚÁö¼Ó
(¿µ¾÷ÀÌÀÍ·ü %) -508.10% -248.95% -64.63% -162.00% -1322.02%


(2) À繫Àû ¾ÈÁ¤¼º
(´ÜÀ§: õ¿ø)
±¸ºÐ 2021³âµµ 2022³âµµ 2023³âµµ 2022³âµµ ¾÷Á¾Æò±Õ 2024³â 1ºÐ±â
(Á¦5±â) (Á¦6±â) (Á¦7±â) (Á¦8±â)
À¯µ¿ºñÀ² 13.32% 37.53% 822.25% 172.12% 638.51%
ºÎäºñÀ² - - 28.97% 94.35% 32.76%
Àç°íÀÚ»ê ȸÀüÀ² 1.18ȸ 1.74ȸ 6.91ȸ 5.77ȸ 0.16ȸ
¸ÅÃâä±Ç ȸÀüÀ² 3.25ȸ 7.62ȸ 7.42ȸ 5.37ȸ 0.52ȸ
Â÷ÀÔ±ÝÀÇÁ¸µµ 21.58% 7.83% 8.82% 28.94% 9.16%
¿µ¾÷È°µ¿À¸·Î ÀÎÇÑ Çö±ÝÈ帧 -3,530,778 -4,082,717 -3,446,180 - -2,696,716


4.°ø¸ðÈÄ À¯Åë°¡´É ¹°·®(º¸È£¿¹¼ö, »óÀåÈÄ À¯ÅëÁֽļö)

±¸ºÐ ÁÖÁÖ¸í °ü°è °ø¸ðÀü Áֽļö °ø¸ðÈÄ Áֽļö °øµ¿¸ñÀûº¸À¯È®¾à Áֽļö
(°ø¸ð ÈÄ ±âÁØ)
Áֽļö ÁöºÐÀ² Áֽļö ÁöºÐÀ² Áֽļö ÁöºÐÀ²
ÃÖ´ëÁÖÁÖ ±èÇÊÇÑ ÃÖ´ëÁÖÁÖ 3,375,000 26.65% 3,375,000 22.55% 3,375,000 22.55%
¿ìÈ£ÁÖÁÖ Àç´Ü¹ýÀÎ - 750,000 5.92% 750,000 5.01% 375,000  2.51%
ÀǾà¹ÙÀÌ¿ÀÄÁ¹öÁ¯½º¿¬±¸´Ü
Çѱ¹°úÇбâ¼ú¿ø - 250,000 1.97% 250,000 1.67% 250,000 1.67%
Ȳ¡Û¡Û - 250,000 1.97% 250,000 1.67% 250,000 1.67%
¿ìÈ£ÁÖÁÖ ¼Ò°è 1,250,000  9.87% 1,250,000  8.35% 875,000  5.85%
ÃÖ´ëÁÖÁÖ ¹× ¿ìÈ£ÁÖÁÖ ¼Ò°è 4,625,000  36.52% 4,625,000  30.90% 4,250,000  28.40%
±âŸ ±âÁ¸ÁÖÁÖ 8,039,600  63.48% 8,039,600  53.72% - -
°ø¸ðÁÖÁÖ - - 2,234,000 14.93% - -
»óÀåÁÖ¼±ÀÎ Àǹ«ÀμöºÐ - - 67,020 0.45% - -
ÃÑÇÕ°è 12,664,600 100.00% 14,965,620 100.00% 4,250,000  28.40%


5.¿ä¾àÀ繫Á¦Ç¥

±¸ºÐ 2024³â 1ºÐ±â 2023³â 2022³â 2021³â
(Á¦8±â 1ºÐ±â) (Á¦7±â) (Á¦6±â) (Á¦5±â)
ȸ°èó¸® ±âÁØ K-IFRS K-IFRS K-IFRS K-IFRS
°¨»çÀÎ(°¨»çÀÇ°ß) »ïµµÈ¸°è¹ýÀÎ »ïÁ¤È¸°è¹ýÀÎ »ïÁ¤È¸°è¹ýÀÎ µµ¿øȸ°è¹ýÀÎ
(°ËÅä) (ÀûÁ¤) (ÀûÁ¤) (ÀûÁ¤)
ÀÚ»ê ¡¡ ¡¡ ¡¡ ¡¡
À¯µ¿ÀÚ»ê 8,918,170,555 10,879,583,162 13,754,307,370 1,994,215,810
  Çö±Ý¹×Çö±Ý¼ºÀÚ»ê 2,192,617,227 3,556,731,008 992,626,508 1,358,487,369
  ´Ü±â±ÝÀ¶»óÇ° 3,000,000,000 4,500,000,000 11,000,000,000
  ¸ÅÃâä±Ç¹×±âŸä±Ç 737,797,073 964,268,041 482,614,445 114,048,804
  ±âŸÀ¯µ¿ÀÚ»ê 494,373,526 298,998,261 166,337,790 78,673,746
  Àç°íÀÚ»ê 2,427,758,219 1,503,381,862 1,100,037,077 440,393,541
  ´ç±â¹ýÀμ¼ÀÚ»ê 65,624,510 56,203,990 12,691,550 2,612,350
ºñÀ¯µ¿ÀÚ»ê 6,549,757,130 5,651,540,392 5,392,250,701 4,957,165,393
  Àå±â±ÝÀ¶»óÇ° 597,577 309,167 622,380 454,966
  ±âŸºñÀ¯µ¿±ÝÀ¶ÀÚ»ê 160,874,316 146,687,468 154,577,665 134,190,039
  À¯ÇüÀÚ»ê 6,179,223,987 5,339,356,766 5,111,574,890 4,677,315,485
  ¹«ÇüÀÚ»ê 209,061,250 165,186,991 125,475,766 145,204,903
ÀÚ»êÃÑ°è 15,467,927,685 16,531,123,554 19,146,558,071 6,951,381,203
ºÎä ¡¡ ¡¡ ¡¡ ¡¡
À¯µ¿ºÎä 1,396,724,130 1,323,149,681 36,646,437,260 14,967,224,759
  À¯µ¿Â÷ÀÔ±Ý 238,360,000 202,660,000 41,960,000
  ¸ÅÀÔ乫¹×±âŸä¹« 906,960,476 804,505,483 320,939,082 262,962,525
  ±âŸÀ¯µ¿ºÎä 133,017,696 193,686,548 88,025,603 44,160,122
  À¯µ¿¸®½ººÎä 98,297,387 92,483,108 75,682,376 69,094,504
  ±âŸÀ¯µ¿±ÝÀ¶ºÎä 36,099,202,912 14,570,267,572
  Ãæ´çºÎä 20,088,571 29,814,542 20,627,287 20,740,036
ºñÀ¯µ¿ºÎä 2,420,097,943 2,390,663,293 2,515,510,357 2,400,542,313
  Àå±âÂ÷ÀÔ±Ý 1,178,040,000 1,255,380,000 1,458,040,000 1,500,000,000
  Àå±â¸ÅÀÔ乫¹×±âŸä¹« 167,515,148 142,587,956 44,295,601
  ºñÀ¯µ¿¸®½ººÎä 957,978,392 876,819,468 920,915,004 820,246,809
  ºñÀ¯µ¿Ãæ´çºÎä 116,564,403 115,875,869 92,259,752 80,295,504
ºÎäÃÑ°è 3,816,822,073 3,713,812,974 39,161,947,617 17,367,767,072
ÀÚº» ¡¡ ¡¡ ¡¡ ¡¡
ÀÚº»±Ý 6,332,300,000 6,332,300,000 100,000,000 100,000,000
ÀÚº»À׿©±Ý 31,330,753,714 31,330,753,714
ÀÚº»Á¶Á¤ 682,850,238 591,974,208 278,812,196 142,439,005
ÀÌÀÍÀ׿©±Ý(°á¼Õ±Ý) -26,694,798,340 -25,437,717,342 -20,394,201,742 -10,658,824,874
ÀÚº»ÃÑ°è 11,651,105,612 12,817,310,580 -20,015,389,546 -10,416,385,869
±¸ºÐ 2024.01.01 ~ 2023.01.01 ~ 2022.01.01 ~ 2021.01.01 ~
2024.03.31 2023.12.31 2022.12.31 2021.12.31
¸ÅÃâ¾× 99,398,351 4,495,088,983 1,337,894,447 526,974,947
¿µ¾÷ÀÌÀÍ(¼Õ½Ç) -1,314,068,310 -2,905,069,801 -3,330,678,562 -2,667,552,347
´ç±â¼øÀÌÀÍ(¼Õ½Ç) -1,257,080,998 -5,043,515,600 -9,735,376,868 -2,620,501,269
ÁÖ´ç¼øÀÌÀÍ(¼Õ½Ç) -99 -660 -1,947 -524


6.µ¿Á¾¾÷ü¿ÍÀÇ À繫Á¤º¸ ºñ±³

[µ¿»ç ¹× ºñ±³È¸»ç 2023³â ¿Â±â ¿ä¾à À繫ÇöȲ]
(´ÜÀ§: ¹é¸¸¿ø)
±¸ ºÐ ¾ÆÀ̺öÅ×Å©³î·ÎÁö Bruker Corporation (ÁÖ2) Carl Zeiss Meditec AG (ÁÖ2,3)
[À¯µ¿ÀÚ»ê] (ÁÖ3) 10,880 2,825,168 2,700,009
[ºñÀ¯µ¿ÀÚ»ê] (ÁÖ3) 5,652 2,722,694 1,583,538
ÀÚ»êÃÑ°è (ÁÖ3) 16,531 5,547,862 4,283,547
[À¯µ¿ºÎä] (ÁÖ3) 1,323 1,569,233 793,181
[ºñÀ¯µ¿ºÎä] (ÁÖ3) 2,391 2,133,693 421,448
ºÎäÃÑ°è (ÁÖ3) 3,714 3,702,926 1,214,630
[ÀÚº»±Ý] (ÁÖ3) 6,332 2,219 126,265
ÀÚº»ÃÑ°è (ÁÖ3) 12,817 1,820.53 3,068,917
¸ÅÃâ¾× 4,495 3,869,888 2,957,482
¿µ¾÷ÀÌÀÍ(¿µ¾÷¼Õ½Ç) -2,905 570,334 467,949
´ç±â¼øÀÌÀÍ(´ç±â¼ø¼Õ½Ç) -5,044 557,671 423,279
 
  ¸ñ·Ïº¸±â  
 IPO °ø¸ðÁÖ Á¤º¸, °ø¸ð°¡, °ø¸ðÁֽļö, °ø¸ðû¾àÀÏÁ¤µîÀº À¯°¡Áõ±Ç½Å°í¼­ ¼ö¸®(±Ý°¨À§)°úÁ¤¿¡¼­ º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.

 



À繫Á¤º¸ »õâÀ¸·Î º¸±â 
Àç   ¹«   »ó   Å   Ç¥
¾ÆÀ̺öÅ×Å©³î·ÎÁö ÁÖ½Äȸ»ç (´ÜÀ§ : ¿ø)
°ú¸ñ 2022³â 12¿ù 31ÀÏ 2021³â 12¿ù 31ÀÏ
 I. À¯µ¿ÀÚ»ê 13,754,307,370 1,994,215,810
II. ºñÀ¯µ¿ÀÚ»ê 5,392,250,701 4,957,165,393
ÀÚ       »ê       ÃÑ       °è 19,146,558,071 6,951,381,203
I. À¯µ¿ºÎä 36,646,437,260 14,967,224,759
II. ºñÀ¯µ¿ºÎä 2,515,510,357 2,400,542,313
ºÎ       ä        ÃÑ      °è 39,161,947,617 17,367,767,072
 I. ÀÚº»±Ý 100,000,000 100,000,000
¥±. ÀÚº»À׿©±Ý - -
¥². ±âŸÀÚº»Ç׸ñ 278,812,196 142,439,005
¥³. ±âŸÆ÷°ý¼ÕÀÍ´©°è¾× - -
¥´. °á¼Õ±Ý (20,394,201,742) (10,658,824,874)
ÀÚ       º»       ÃÑ       °è (20,015,389,546) (10,416,385,869)
ºÎ  Ã¤  ¹×  ÀÚ  º»  ÃÑ  °è 19,146,558,071 6,951,381,203

Æ÷   °ý   ¼Õ   ÀÍ   °è   »ê   ¼­
¾ÆÀ̺öÅ×Å©³î·ÎÁö ÁÖ½Äȸ»ç (´ÜÀ§ : ¿ø)
°ú¸ñ 2022³â 12¿ù 31ÀÏ 2021³â 12¿ù 31ÀÏ
I. ¸ÅÃâ¾× 1,337,894,447 526,974,947
II. ¸ÅÃâ¿ø°¡ 1,178,320,449 649,917,946
III. ¸ÅÃâÃÑÀÌÀÍ 159,573,998 (122,942,999)
IV. ÆǸźñ¿Í°ü¸®ºñ 3,490,252,560 2,554,609,348
V. ¿µ¾÷¼Õ½Ç (3,330,678,562) (2,677,552,347)
¥µ. ±âŸ¼öÀÍ 95,607,698 34,285,627
¥¶. ±âŸºñ¿ë 37,721,258 679,908
¥·. ±ÝÀ¶¼öÀÍ 225,502,540 1,175,688,793
¥¸. ±ÝÀ¶ºñ¿ë 6,688,087,286 1,152,243,434
X. ¹ýÀμ¼ºñ¿ëÂ÷°¨Àü¼ø¼Õ½Ç (9,735,376,868) (2,620,501,269)
XI. ¹ýÀμ¼ºñ¿ë - -
XII. ´ç±â¼ø¼Õ½Ç (9,735,376,868) (2,620,501,269)
XIII. ±âŸÆ÷°ý¼ÕÀÍ - -
X¥³. ÃÑÆ÷°ý¼Õ½Ç (9,735,376,868) (2,620,501,269)

ÀÚ   º»   º¯   µ¿   Ç¥
¾ÆÀ̺öÅ×Å©³î·ÎÁö ÁÖ½Äȸ»ç (´ÜÀ§ : ¿ø)
°ú¸ñ ÀÚº»±Ý ÀÚº»À׿©±Ý ±âŸÀÚº»Ç׸ñ ±âŸÆ÷°ý¼ÕÀÍ
´©°è¾×
ÀÌÀÍÀ׿©±Ý ÃÑ°è
2021.01.01. (Àü±âÃÊ) 100,000,000 - 50,177,877 - (8,038,323,605) (7,888,145,728)
    Áֽ帻óºñ¿ë - - 92,261,128 - - 92,261,128
    ´ç±â¼ø¼Õ½Ç - - - - (2,620,501,269) (2,620,501,269)
2021.12.31. (Àü±â¸») 100,000,000 - 142,439,005 - (10,658,824,874) (10,416,385,869)
2022.01.01. (´ç±âÃÊ) 100,000,000 - 142,439,005 - (10,658,824,874) (10,416,385,869)
    Áֽ帻óºñ¿ë - - 136,373,191 - - 136,373,191
    ´ç±â¼ø¼Õ½Ç - - - - (9,735,376,868) (9,735,376,868)
2022.12.31. (´ç±â¸») 100,000,000 - 278,812,196 - (20,394,201,742) (20,015,389,546)

¾ÆÀ̺öÅ×Å©³î·ÎÁö IPO°ø¸ð,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ðÀÏÁ¤,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ðÁÖ,¾ÆÀ̺öÅ×Å©³î·ÎÁö »óÀå,¾ÆÀ̺öÅ×Å©³î·ÎÁö û¾àÀÏÁ¤,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ð°¡,¾ÆÀ̺öÅ×Å©³î·ÎÁö û¾à°æÀï·ü,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ðÁֽļö,¾ÆÀ̺öÅ×Å©³î·ÎÁö È®Á¤°ø¸ð°¡,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ð±Ý¾×,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ðºÐ¼®,¾ÆÀ̺öÅ×Å©³î·ÎÁö °ø¸ðû¾à,°ø¸ðÁֺм®,°ø¸ðÁÖû¾àÀÏÁ¤,°ø¸ðû¾àÀÏÁ¤

¡Ø IPO°ø¸ðÁÖ Á¤º¸, °ø¸ðû¾àÀÏÁ¤ µîÀº Áõ±Ç½Å°í¼­ ¼ö¸®°úÁ¤¿¡¼­ º¯°æµÉ ¼ö ÀÖÀ¸¸ç ÀԷ¿À·ùµµ ¹èÁ¦ ¸øÇÏ´Ï º»ÀΠåÀÓÇÏ¿¡ ÅõÀÚ¹Ù¶ø´Ï´Ù

¾ÆÀ̵ð,ºñ¹Ð¹øȣã±â ¹«·áȸ¿ø°¡ÀÔ
 ÃÖ±Ù IPO û±¸Á¾¸ñ
10/04 LGCNS
09/26 KB½ºÆÑ31È£
09/24 ³ª¿ì·Îº¸Æ½½º(±¸.
09/20 ´ëÁø÷´Ü¼ÒÀç
09/19 Ƽ¿¢½º¾Ë·Îº¸Æ½½º
09/10 ¸Þ¸¦·Î·¦
 ÃÖ±Ù IPO ½ÂÀÎÁ¾¸ñ
09/27 ±³º¸½ºÆÑ17È£
09/27 ¿À¸§Å׶óǻƽ
09/27 º¤Æ®
09/26 ¾²¸®¿¡ÀÌ·ÎÁ÷½º
09/26 ¿ÍÀÌÁî³Ó
09/12 ¿ÂÄÚÅ©·Î½º
 IPO °ø¸ðÁÖ Ã»¾àÀÏÁ¤
10/07 ÀνºÇǾð
10/07 ÇÑÄÍ
10/07 ¼¿ºñ¿Â
10/10 ·ç¹Ì¸£
10/10 ¿ÍÀÌÁ¦À̸µÅ©
10/14 ¿¡ÀÌÄ¡¿£¿¡½ºÇÏÀÌ
 IPO ½Å±Ô»óÀå ÀÏÁ¤
10/16 ¼¿ºñ¿Â
10/18 ÀνºÇǾð
10/21 ·ç¹Ì¸£
10/21 ½ÅÇѽºÆÑ14È£
10/22 ÇÑÄÍ
10/25 ¿¡ÀÌÄ¡¿£¿¡½ºÇÏÀÌ
 

  °ø¸ðÁÖ ´º½º
ÀνºÇǾð,ÇÑÄÍ,¼¿ºñ¿Â
ÆÄÀθ޵ñ½º, ½ÇÀû µé¾¦
Àå¿Ü¸ö°ª 8.5Á¶ Èǽ¡¦L
"NFC¿ë ¹ÝµµÃ¼&quo

  °ø¸ðÁÖ ÀÏÁ¤
³ë¸Ó½º, °ø¸ðû¾à ÀÏÁ¤
¾²¸®¿¡ÀÌ·ÎÁ÷½º, °ø¸ðû
ÆÄÀθ޵ñ½º, °ø¸ðû¾à
¿À¸§Å׶óǻƽ, °ø¸ðû¾à
ȸ»ç¼Ò°³±¤°í¹®ÀDZâ¾÷Á¤º¸¹®ÀǾ÷¹«Á¦ÈÞ¹®ÀÇ 38¿¡¹Ù¶õ´Ù¾÷¹«Á¦ÈÞ»ç»çÀÌÆ®¸Ê°³ÀÎÁ¤º¸Ãë±Þ¹æħÁ¤º¸Á¦°øÀ±¸®Á¤Ã¥ÅõÀÚÀÚÀ¯ÀÇ»çÇ×
38Ä¿¹Â´ÏÄÉÀÌ¼Ç ·Î°í
Copyright¨Ï 38Ä¿¹Â´ÏÄÉÀ̼Ç. All rights reserved.       »ïÆÈÄ¿¹Â´ÏÄÉÀ̼Ç,38stock,»ïÆÈ,38
»óÈ£ ¢ß38Ä¿¹Â´ÏÄÉÀ̼Ǡ  ´ëÇ¥ÀÌ»ç ¼­¼º±â   »ç¾÷ÀÚµî·Ï¹øÈ£ 108-81-21496   Åë½ÅÆǸž÷ ½Å°í¹øÈ£ Á¦19-1912È£
ÁÖ¼Ò: ¼­¿ï½Ã ±¸·Î±¸ µðÁöÅзΠ26±æ 111, 407È£  ÀüÈ­ 1644-3830 Æѽº 02-6124-6333 ±â»ç¹è¿­ Ã¥ÀÓÀÚ ÀÌ¿ë¹Î ±â»ç¹è¿­ ±âº»¹æħ
Àå¿ÜÁֽĽÃÀå, Àå¿ÜÁÖ½Ä ½Ã¼¼Ç¥, Àå¿ÜÁֽĸŸÅ, ºñ»óÀåÁÖ½Ä ½Ã¼¼Ç¥, ºñ»óÀå¸Å¸Å, Àå¿ÜÁֽİŷ¡, Àå¿ÜÁÖ½Ä ÇöÀç°¡, Àå¿ÜÁÖ½Ä ±â¾÷ºÐ¼®,IPO°ø¸ð
º» °Ô½ÃÆÇ¿¡ °Ô½ÃµÈ Á¤º¸³ª ÀÇ°ßÀº 38Ä¿¹Â´ÏÄÉÀ̼ǰú ¾Æ¹«·± °ü·ÃÀÌ ¾øÀ¸¸ç °Ô½Ã¹°ÀÇ ³»¿ë°ú °ü·ÃÇÏ¿© ¹ß»ýÇÑ ¹ýÀû Ã¥ÀÓÀº °Ô½ÃÀÚ
¶Ç´Â À̸¦ ¿­¶÷ÇÏ´Â ÀÌ¿ëÀÚ°¡ ºÎ´ãÇØ¾ß Çϸç, ´ç»ç¿¡¼­ Á¦°øÇÏ´Â Áõ±ÇÁ¤º¸¿Í ºÐ¼®ÀÚ·á ¹× ÁֽĽü¼´Â ´Ü¼øÁ¤º¸Á¦°øÀ» ¸ñÀûÀ¸·Î Çϸç
Àå¿ÜÁÖ½Ä °Å·¡¸¦ ¸ñÀûÀ¸·Î ÇÏÁö ¾ÊÀ½. ÅõÀÚ°£ ¸Å¸Å´Â ÀÏü °³ÀÔÇÏÁö ¾ÊÀ¸¸ç Á¤º¸ ¹× °Å·¡¿¡ ´ëÇÑ ¼ÕÀÍÃ¥ÀÓÀº ÅõÀÚÀÚ º»Àο¡°Ô ÀÖ½À´Ï´Ù.